← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksVTRAnalysis
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets
Analysis OverviewBuyUpdated May 1, 2026

VTR logoVentas, Inc. (VTR) Stock Analysis

Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.

Analyst consensus
Buy
Covering
32
analysts
19 bullish · 2 bearish · 32 covering VTR
Strong Buy
0
Buy
19
Hold
11
Sell
2
Strong Sell
0
Consensus Target
$91
+4.6% vs today
Scenario Range
$5 – $17
Model bear to bull value window
Coverage
32
Published analyst ratings
Valuation Context
118.3x
Forward P/E · Market cap $41.3B

Decision Summary

Ventas, Inc. (VTR) is rated Buy by Wall Street. 19 of 32 analysts are bullish, with a consensus target of $91 versus a current price of $86.78. That implies +4.6% upside, while the model valuation range spans $5 to $17.

Note: Strong analyst support doesn't guarantee returns. At 118.3x forward earnings, much of the optimism may already be priced in. Use the scenario range to judge whether the upside justifies the risk.
Upside case
Street consensus points to +4.6% upside. The bull scenario stretches to -80.6% if VTR re-rates higher.
Downside frame
The bear case maps to $5 — a -94.1% drop — if investor confidence compresses the multiple sharply.

VTR price targets

Three scenarios for where VTR stock could go

Current
~$87
Confidence
63 / 100
Updated
May 1, 2026
Where we are now
you are here · $87
Bear · $5
Base · $54
Bull · $17
Current · $87
Bear
$5
Base
$54
Bull
$17
Upside case

Bull case

$17-80.6%

The bull case prices VTR at 23x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.

Market caseClosest to today

Base case

$54-37.3%

At 74x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.

Stress case

Bear case

$5-94.1%

If investor confidence fades or macro conditions deteriorate, a 111x multiple contraction could push VTR down roughly 94% from where it trades now.

Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

VTR logo

Ventas, Inc.

VTR · NYSEReal EstateREIT - Healthcare FacilitiesDecember year-end
Data as of May 1, 2026

Ventas is a healthcare-focused real estate investment trust that owns and operates senior housing communities, medical office buildings, and life science research facilities. It generates revenue primarily through rental income from its diversified portfolio — roughly 60% from senior housing, 25% from medical office buildings, and 15% from life science and hospital properties. The company's competitive advantage lies in its scale, diversified healthcare property portfolio, and long-term relationships with leading healthcare operators across multiple care settings.

Market Cap
$41.3B
Revenue TTM
$6.1B
Net Income TTM
$260M
Net Margin
4.2%

VTR Revenue and Earnings Performance

Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.

EPS Beat Rate
75%Exceptional
12 quarters tracked
Revenue Beat Rate
92%Exceptional
vs consensus estimates
Avg EPS Surprise
+350.3%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q3 2025
Q4 2025
Q1 2026
Q2 2026

Last 4 Quarters

EPS beats: 3 of 4
Q3 2025
EPS
$0.87/$0.85
+2.4%
Revenue
$1.4B/$1.4B
+1.1%
Q4 2025
EPS
$0.88/$0.87
+1.1%
Revenue
$1.5B/$1.5B
-2.8%
Q1 2026
EPS
$0.15/$0.10
+49.0%
Revenue
$1.6B/$1.5B
+4.1%
Q2 2026
EPS
$0.11/$0.12
-10.5%
Revenue
$1.7B/$1.6B
+4.5%
QuarterEPS (Actual / Est)EPS SurpriseRevenue (Actual / Est)Rev Surprise
Q3 2025$0.87/$0.85+2.4%$1.4B/$1.4B+1.1%
Q4 2025$0.88/$0.87+1.1%$1.5B/$1.5B-2.8%
Q1 2026$0.15/$0.10+49.0%$1.6B/$1.5B+4.1%
Q2 2026$0.11/$0.12-10.5%$1.7B/$1.6B+4.5%
FY1–FY2 Estimates
Revenue Outlook
FY1
$7.0B
+13.6% YoY
FY2
$7.9B
+14.0% YoY
EPS Outlook
FY1
$0.60
+12.5% YoY
FY2
$0.68
+13.0% YoY
Trailing FCF (TTM)$1.4B
FCF Margin: 22.4%
Next Earnings
—
Expected EPS
—
Expected Revenue
—

VTR beat EPS estimates in 3 of 4 tracked quarters. A strong delivery record supports forward estimate credibility.

VTR Revenue Breakdown by Segment

Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.

Latest disclosure
FY 2025
Total disclosed revenue $5.8B

Product Mix

Latest annual revenue by segment or product family

Senior Living Operations
74.0%
+26.8% YoY

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix

Geographic Mix

Latest annual revenue by reported region

UNITED STATES
89.3%
+19.3% YoY

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix
Senior Living Operations is the largest disclosed segment at 74.0% of FY 2025 revenue, up 26.8% YoY.
UNITED STATES is the largest reported region at 89.3%, up 19.3% YoY.
See full revenue history

VTR Valuation Snapshot

Current multiples compared to the S&P 500, the company's sector, and its own five-year average.

Relative Value Signal
Significantly Overvalued

Fair value est. $59 — implies -33.0% from today's price.

Premium to Fair Value
33.0%
above fair value
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
VTR
160.7x
vs
S&P 500
25.1x
+540% premium
vs Real Estate Trailing P/E
VTR
160.7x
vs
Real Estate
24.1x
+566% premium
vs VTR 5Y Avg P/E
Today
160.7x
vs
5Y Average
143.3x
+12% premium
Forward PE
118.3x
S&P 500
19.1x
+520%
Real Estate
26.4x
+349%
5Y Avg
—
—
Trailing PE
160.7x
S&P 500
25.1x
+540%
Real Estate
24.1x
+566%
5Y Avg
143.3x
+12%
PEG Ratio
—
S&P 500
1.72x
—
Real Estate
1.25x
—
5Y Avg
—
—
EV/EBITDA
24.4x
S&P 500
15.2x
+60%
Real Estate
16.7x
+46%
5Y Avg
19.2x
+27%
Price/FCF
31.3x
S&P 500
21.1x
+49%
Real Estate
15.4x
+103%
5Y Avg
22.6x
+38%
Price/Sales
7.1x
S&P 500
3.1x
+126%
Real Estate
3.0x
+138%
5Y Avg
5.0x
+42%
Dividend Yield
2.14%
S&P 500
1.87%
+15%
Real Estate
4.66%
-54%
5Y Avg
3.35%
-36%
MetricVTRS&P 500· delta vs VTRReal Estate5Y Avg VTR
Forward PE118.3x
19.1x+520%
26.4x+349%
—
Trailing PE160.7x
25.1x+540%
24.1x+566%
143.3x+12%
PEG Ratio—
1.72x
1.25x
—
EV/EBITDA24.4x
15.2x+60%
16.7x+46%
19.2x+27%
Price/FCF31.3x
21.1x+49%
15.4x+103%
22.6x+38%
Price/Sales7.1x
3.1x+126%
3.0x+138%
5.0x+42%
Dividend Yield2.14%
1.87%
4.66%
3.35%
VTR trades above S&P 500 benchmarks on 5 of 5 measured multiples — commands a broad premium across most valuation dimensions.

Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.

Open valuation tool

VTR Financial Health

Verdict
Adequate

VTR pays 2.1% total shareholder yield with 13.4% operating margin. Leverage is structural for REITs — debt capacity matters more than absolute ratio.

Property Operations

Revenue, margins, and distribution coverage

Revenue (TTM)
Trailing-twelve-month sales base
$6.1B
Revenue Growth
TTM vs prior year
+20.7%
Gross Margin
Gross profit as a share of revenue
-4.3%
Operating Margin
Operating income divided by revenue
13.4%
Net Margin
Net income divided by revenue
4.2%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$0.54
Operating Margin
NOI-equivalent margin — key for REIT property economics
13.4%

Capital Quality

ROIC, leverage, and debt serviceability

ROIC
Return on invested capital — primary competitive quality signal
2.5%
ROA
Return on assets, trailing twelve months
1.0%
Cash & Equivalents
Liquid assets on the balance sheet
$741M
Net Debt
Total debt minus cash
$12.5B
Leverage (Net Debt / FCF)
REITs carry structural leverage — higher ratios are expected
9.1× FCF

Asset-heavy model means debt/FCF above 10× is common and not a distress signal.

ROE
Return on equity, trailing twelve months
2.1%

Shareholder Returns

How capital is returned to owners

Total shareholder yield
2.1%
Dividend
2.1%
Buyback
0.0%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$0
Dividend / Share
Annualized trailing dividend per share
$1.86
Payout Ratio
Share of earnings distributed as dividends
342.1%
Shares Outstanding
Current diluted share count
475M

All figures from the trailing twelve months. REITs carry structural leverage — debt/FCF ratios above 10× are normal and do not indicate distress.

Open full ratios page

VTR Stock Risk Factors

Key factors that could pressure the stock price, compress the multiple, or weigh on future results.

AI analysis · updated April 11, 2026

01
High Risk

Debt Burden

Ventas carries a substantial debt load, with leverage exceeding many peers. This exposes the REIT to interest rate risk, as rising rates could increase borrowing costs and compress cash flow. The company is actively using equity to improve its credit profile, but the current debt level remains a significant risk.

02
High Risk

Rich Valuation

Ventas trades at high valuation multiples, with a P/B ratio above the S&P 500 average and an EV/EBITDA considered "rich". This implies the market expects near‑perfect growth, creating a risk if performance fails to meet lofty expectations. A downturn could lead to a sharp decline in share price.

03
Medium

Operator Performance

Ventas relies on third‑party operators for its Senior Housing Operating Portfolio. If operators underperform or labor cost pressures persist, margin expansion could slow, impacting profitability. The dependence on external operators adds execution risk.

04
Medium

Rising Operating Expenses

Property‑level operating expenses for senior housing have increased, indicating a need for Ventas to optimize operational efficiency. Higher costs could erode operating margins if not controlled. The company must manage expense growth to maintain profitability.

05
Medium

Competitive Landscape

The healthcare real estate market is highly competitive, with many players vying for properties and tenants. Intense competition can limit Ventas's ability to raise rents and drive profitability. Market share erosion could pressure earnings.

06
Lower

Market Dependence

Ventas's performance is closely tied to the healthcare and senior living sectors, which are subject to regulatory changes and economic fluctuations. Policy shifts or downturns could reduce occupancy rates and rental income. This sector concentration adds risk to the company's revenue stream.

These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.

Why VTR Stock Could Outperform

Structural drivers behind the upside case and why the stock could outperform over the next 12 months.

AI analysis · updated April 11, 2026

01

Analyst Optimism

Multiple analysts have issued "Buy" ratings for VTR, with a consensus rating of "Moderate Buy" and several recent upgrades and price target increases. The strong analyst sentiment signals confidence in the company’s trajectory.

02

Revenue Growth 21.7% YoY

Ventas has demonstrated year‑over‑year revenue growth of approximately 21.7%, outpacing U.S. market benchmarks. This robust top‑line expansion supports continued scale and market share gains.

03

Improving Profitability & FFO

The company has shown improving profit margins and a return to profitability, with Funds From Operations (FFO) rising significantly. Consistent EPS beats in recent quarters further underscore operational strength.

04

Senior Housing Demand Surge

Ventas’ portfolio includes a significant number of senior housing communities, positioning it to benefit from an aging population. Demand for senior housing is expected to surge while supply growth remains low, creating a favorable supply‑demand dynamic.

05

Dividend Increase & Strategic Growth

Ventas recently increased its dividend, signaling confidence in cash flow and rewarding shareholders. The company is actively investing in senior housing, targeting profitable organic and external growth.

A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.

Price target page

VTR Stock Price Performance

52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.

Current Price
$86.78
52W Range Position
94%
52-Week Range
Current price plotted between the 52-week low and high.
94% through range
52-Week Low
$61.76
+40.5% from the low
52-Week High
$88.50
-1.9% from the high
1 Month
+4.62%
3 Month
+8.69%
YTD
+12.2%
1 Year
+30.3%
3Y CAGR
+21.9%
5Y CAGR
+10.2%
10Y CAGR
+2.8%

Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.

Full price historyP/E history

VTR vs Peers

Valuation, growth, and margin comparison against the closest publicly traded peers for this company.

Peer Set
Accurate peer set
Forward PE
118.3x
vs 26.5x median
+347% above peer median
Revenue Growth
+13.6%
vs +7.8% median
+74% above peer median
Net Margin
4.2%
vs 19.2% median
-78% below peer median
CompanyMkt CapFwd PERev GrwMarginRatingUpside
VTR
VTR
Ventas, Inc.
$41.3B118.3x+13.6%4.2%Buy+4.6%
WEL
WELL
Welltower Inc.
$150.1B78.9x+23.6%12.3%Buy+5.7%
HR
HR
Healthcare Realty Trust Incorporated
$6.9B—+0.7%-17.5%Hold-3.0%
OHI
OHI
Omega Healthcare Investors, Inc.
$13.7B23.4x+7.8%51.0%Hold+6.5%
SBR
SBRA
Sabra Health Care REIT, Inc.
$5.1B29.5x+8.3%19.2%Hold+4.0%
NHI
NHI
National Health Investors, Inc.
$3.5B21.6x+4.0%36.8%Hold+16.8%

This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.

VTR Dividend and Capital Return

VTR returns 2.1% total yield, led by a 2.14% dividend.

Dividend SustainableFCF Adequate
Total Shareholder Yield
2.1%
Dividend + buyback return per year
Buyback Yield
0.0%
Dividend Yield
2.14%
Payout Ratio
3.4%
How VTR Splits Its Return
Div 2.14%
Dividend 2.14%Buybacks 0.0%

Dividend Profile

Yield, cadence, and growth quality

Dividend / Share
Trailing annualized cash dividend
$1.86
Growth Streak
Consecutive years of dividend increases
1Y
3Y Div CAGR
2.2%
5Y Div CAGR
-2.2%
Ex-Dividend Date
—
Payment Cadence
Quarterly
4 payments over the last 12 months

Buyback Engine

How much per-share support comes from repurchases

Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$0
Estimated Shares Retired
0
Approx. Share Reduction
0.0%
Shares Outstanding
Current diluted share count from the screening snapshot
475M
YearDiv / ShareYoY GrwBB YieldTotal Yield
2026$0.52———
2025$1.92+6.7%0.0%2.4%
2024$1.800.0%0.0%3.0%
2023$1.800.0%0.0%3.6%
2022$1.800.0%0.0%4.3%
Full dividend history
FAQ

VTR Investor Questions

Common questions answered from live analyst data and company financials.

7 questions
01

Is Ventas, Inc. (VTR) stock a buy or sell in 2026?

Ventas, Inc. (VTR) is rated Buy by Wall Street analysts as of 2026. Of 32 analysts covering the stock, 19 rate it Buy or Strong Buy, 11 rate it Hold, and 2 rate it Sell or Strong Sell. The consensus 12-month price target is $91, implying +4.6% from the current price of $87. The bear case scenario is $5 and the bull case is $17.

02

What is the VTR stock price target for 2026?

The Wall Street consensus price target for VTR is $91 based on 32 analyst estimates. The high-end target is $100 (+15.2% from today), and the low-end target is $85 (-2.1%). The base case model target is $54.

03

Is Ventas, Inc. (VTR) stock overvalued in 2026?

VTR trades at 118.3x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals significantly overvalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.

04

What are the main risks for Ventas, Inc. (VTR) stock in 2026?

The primary risks for VTR in 2026 are: (1) Debt Burden — Ventas carries a substantial debt load, with leverage exceeding many peers. (2) Rich Valuation — Ventas trades at high valuation multiples, with a P/B ratio above the S&P 500 average and an EV/EBITDA considered "rich". (3) Operator Performance — Ventas relies on third‑party operators for its Senior Housing Operating Portfolio. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.

05

What is Ventas, Inc.'s revenue and earnings forecast?

Analyst consensus estimates VTR will report consensus revenue of $7.0B (+13.6% year-over-year) and EPS of $0.60 (+12.5% year-over-year) for the upcoming fiscal year. The following year, analysts project $7.9B in revenue.

06

When does Ventas, Inc. (VTR) report its next earnings?

A confirmed upcoming earnings date for VTR is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.

07

How much free cash flow does Ventas, Inc. generate?

Ventas, Inc. (VTR) generated $1.4B in free cash flow over the trailing twelve months — a free cash flow margin of 22.4%. VTR returns capital to shareholders through dividends (2.1% yield) and share repurchases ($0 TTM).

Continue Your Research

Ventas, Inc. Stock Overview

Price chart, key metrics, financial statements, and peers

VTR Valuation Tool

Is VTR cheap or expensive right now?

Compare VTR vs WELL

Side-by-side financials, valuation, and ratings

Deep Dive Analysis

VTR Price Target & Analyst RatingsVTR Earnings HistoryVTR Revenue HistoryVTR Price HistoryVTR P/E Ratio HistoryVTR Dividend HistoryVTR Financial Ratios

Related Analysis

Welltower Inc. (WELL) Stock AnalysisHealthcare Realty Trust Incorporated (HR) Stock AnalysisOmega Healthcare Investors, Inc. (OHI) Stock AnalysisCompare VTR vs HRS&P 500 Mega Cap Technology Stocks
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.